The largest price increases came from Leadiant Pharmaceuticals, a subsidiary of Italy-based Essetifin. Leadiant raised prices ...

Anti-obesity drug Mounjaro is set rack up sales of nearly £22bn a year by 2030. But Trump's 'America First' policies mean Britons could soon be paying more for the 'King Kong' of weight-loss jabs ...

Vizient, Inc. released its new Spend Management Outlook representing the best estimate of the change in the price of pharmaceuticals, medical devices and supplies, capital equipment and services ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a ...

The Texas A&M women’s golf team finished in third behind Kynadie Adams’ 2-under 70 round that gave her runner-up honors at the Match in the Desert [Read More...] ...

UT said it doesn't know how pausing federal grants would affect research. U.S. Rep. Lloyd Doggett called it "an abuse of ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

UT receives 13% of its budget from a state endowment and 10% from the state's general fund. Early budget drafts show what UT ...

Early moves by the president raise questions about what direction his second-term policy on drug costs will take.